Revenue
attach_money162M USD
-
TARSTarsus Pharmaceuticals, Inc.$ --
Tarsus Pharmaceuticals, Inc.
TARS
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2026 Q1Updated: 03/31/2026
Operating Income
trending_up-6M USD
-
Net Income
verified-7M USD
-
EPS
paid-0.16$
-
Revenue
$162.1M
BEAT
$149.4M
$162.1M
$149.4M
$162.1M
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-
Net Income
$-7M
BEAT
$-15.7M
$-7M
$-15.7M
$-7M
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-
Surprise History
ActualEstimate
FY2025BEAT